Healthcare provider profile · identity verified

Scott C Forster, M.D.

Hospitalist · PAINESVILLE, OH · NPI 1427374990

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	368	67
Furosemide	Furosemide	275	48
Eliquis	Apixaban	269	36
Potassium Chloride	Potassium Chloride	233	39
Trazodone Hcl	Trazodone Hcl	220	44
Levothyroxine Sodium	Levothyroxine Sodium	218	37
Sertraline Hcl	Sertraline Hcl	217	36
Tamsulosin Hcl	Tamsulosin Hcl	184	30
Amlodipine Besylate	Amlodipine Besylate	169	37
Gabapentin	Gabapentin	162	32
Hydroxyzine Hcl	Hydroxyzine Hcl	143	37
Metoprolol Tartrate	Metoprolol Tartrate	142	24
Warfarin Sodium	Warfarin Sodium	141	suppressed
Donepezil Hcl	Donepezil Hcl	133	18
Buspirone Hcl	Buspirone Hcl	125	23
Fluoxetine Hcl	Fluoxetine Hcl	114	14
Carbidopa-Levodopa	Carbidopa/Levodopa	109	12
Mirtazapine	Mirtazapine	99	23
Finasteride	Finasteride	95	15
Omeprazole	Omeprazole	92	20
Quetiapine Fumarate	Quetiapine Fumarate	88	15
Pantoprazole Sodium	Pantoprazole Sodium	87	19
Lisinopril	Lisinopril	83	15
Duloxetine Hcl	Duloxetine Hcl	80	11
Januvia	Sitagliptin Phosphate	78	suppressed
Divalproex Sodium	Divalproex Sodium	77	11
Midodrine Hcl	Midodrine Hcl	77	15
Meloxicam	Meloxicam	74	12
Oxybutynin Chloride Er	Oxybutynin Chloride	74	suppressed
Metoprolol Succinate	Metoprolol Succinate	72	16
Escitalopram Oxalate	Escitalopram Oxalate	71	suppressed
Levetiracetam	Levetiracetam	66	suppressed
Allopurinol	Allopurinol	64	suppressed
Citalopram Hbr	Citalopram Hydrobromide	64	suppressed
Cephalexin	Cephalexin	63	22
Famotidine	Famotidine	60	11
Losartan Potassium	Losartan Potassium	59	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	16
Carvedilol	Carvedilol	53	11
Hydralazine Hcl	Hydralazine Hcl	53	12
Torsemide	Torsemide	53	suppressed
Spironolactone	Spironolactone	48	suppressed
Latanoprost	Latanoprost	46	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	12
Ondansetron Hcl	Ondansetron Hcl	44	25
Metformin Hcl	Metformin Hcl	43	11
Trulicity	Dulaglutide	43	suppressed
Myrbetriq	Mirabegron	42	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Memantine Hcl	Memantine Hcl	41	suppressed
Humalog Kwikpen U-100	Insulin Lispro	39	suppressed
Montelukast Sodium	Montelukast Sodium	38	suppressed
Vancomycin Hcl	Vancomycin Hcl	38	suppressed
Olanzapine	Olanzapine	35	11
Simvastatin	Simvastatin	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	12
Hydrochlorothiazide	Hydrochlorothiazide	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	15
Lorazepam	Lorazepam	28	18
Venlafaxine Hcl	Venlafaxine Hcl	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	15
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Primidone	Primidone	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Timolol Maleate	Timolol Maleate	23	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	22	13
Budesonide	Budesonide	21	suppressed
Digoxin	Digoxin	21	suppressed
Risperidone	Risperidone	21	suppressed
Sodium Chloride	0.9 % Sodium Chloride	20	suppressed
Amantadine	Amantadine Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Daptomycin	Daptomycin	17	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	17	suppressed
Nystatin	Nystatin	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Albuterol Sulfate	Albuterol Sulfate	16	suppressed
Atenolol	Atenolol	16	suppressed
Baclofen	Baclofen	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Clozapine	Clozapine	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Cholestyramine Light	Cholestyramine	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Azithromycin	Azithromycin	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	14	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Letrozole	Letrozole	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Cefepime Hcl	Cefepime Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Prednisone	Prednisone	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Acetazolamide	Acetazolamide	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Cefazolin Sodium	Cefazolin Sodium	11	suppressed
Klayesta	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error